Search research articles
Contact Us
Filters
Showing results (11-20 of 97) with videos related to
Page
of 10
Sort By:
Surgical Oncology
|
May 12, 1998
Advances in the early detection, diagnosis, and staging of pancreatic cancer
A Riker, S K Libutti, D L Bartlett
The Oncologist
|
October 21, 2000
Current status of isolated hepatic perfusion with or without tumor necrosis factor for the treatment of unresectable cancers confined to liver
H R Alexander, D L Bartlett, S K Libutti
The Cancer Journal From Scientific American
|
February 19, 1998
Isolated hepatic perfusion: a potentially effective treatment for patients with metastatic or primary cancers confined to the liver
H R Alexander, D L Bartlett, S K Libutti
Nuclear Medicine and Biology
|
November 25, 2000
Measuring tumor blood flow with H(2)(15)O: practical considerations
S L Bacharach, S K Libutti, J A Carrasquillo
Current Oncology (Toronto, Ont.)
|
June 6, 2013
Liposomal doxorubicin plus radiofrequency ablation for complete necrosis of a hepatocellular carcinoma
C W Hong, S K Libutti, B J Wood
Anesthesia and Analgesia
|
July 1, 1995
Airway management during retrieval of the very large aspirated foreign body: a method for the flexible bronchoscope
R J Downey, S K Libutti, L Gorenstein, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 23, 2000
Endothelial monocyte-activating polypeptide II, a tumor-derived cytokine that plays an important role in inflammation, apoptosis, and angiogenesis
A C Berger, G Tang, H R Alexander, et al.
Magnetic Resonance Imaging
|
April 4, 2000
Ferumoxide-enhanced MRI in patients with colorectal cancer and rising CEA: surgical correlation in early recurrence
B Said, J A McCart, S K Libutti, et al.
Journal of the American College of Surgeons
|
November 21, 2000
Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies
S K Libutti, D L Barlett, D L Fraker, et al.
Urology
|
March 30, 1999
Laparoscopic cytoreductive nephrectomy as preparation for administration of systemic interleukin-2 in the treatment of metastatic renal cell carcinoma: a pilot study
M M Walther, J C Lyne, S K Libutti, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 97) with videos related to
Sort By:
Page
of 10
Surgical Oncology
|
May 12, 1998
Advances in the early detection, diagnosis, and staging of pancreatic cancer
A Riker, S K Libutti, D L Bartlett
The Oncologist
|
October 21, 2000
Current status of isolated hepatic perfusion with or without tumor necrosis factor for the treatment of unresectable cancers confined to liver
H R Alexander, D L Bartlett, S K Libutti
The Cancer Journal From Scientific American
|
February 19, 1998
Isolated hepatic perfusion: a potentially effective treatment for patients with metastatic or primary cancers confined to the liver
H R Alexander, D L Bartlett, S K Libutti
Nuclear Medicine and Biology
|
November 25, 2000
Measuring tumor blood flow with H(2)(15)O: practical considerations
S L Bacharach, S K Libutti, J A Carrasquillo
Current Oncology (Toronto, Ont.)
|
June 6, 2013
Liposomal doxorubicin plus radiofrequency ablation for complete necrosis of a hepatocellular carcinoma
C W Hong, S K Libutti, B J Wood
Anesthesia and Analgesia
|
July 1, 1995
Airway management during retrieval of the very large aspirated foreign body: a method for the flexible bronchoscope
R J Downey, S K Libutti, L Gorenstein, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 23, 2000
Endothelial monocyte-activating polypeptide II, a tumor-derived cytokine that plays an important role in inflammation, apoptosis, and angiogenesis
A C Berger, G Tang, H R Alexander, et al.
Magnetic Resonance Imaging
|
April 4, 2000
Ferumoxide-enhanced MRI in patients with colorectal cancer and rising CEA: surgical correlation in early recurrence
B Said, J A McCart, S K Libutti, et al.
Journal of the American College of Surgeons
|
November 21, 2000
Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies
S K Libutti, D L Barlett, D L Fraker, et al.
Urology
|
March 30, 1999
Laparoscopic cytoreductive nephrectomy as preparation for administration of systemic interleukin-2 in the treatment of metastatic renal cell carcinoma: a pilot study
M M Walther, J C Lyne, S K Libutti, et al.
Page
of 10